They showed that early stages of T2D pathogenesis at which subjects exhibited impaired glucose tolerance and a loss of first-phase insulin release but are not insulin resistant and are not yet diabetic exhibit significant functional deterioration and exhaustion, while their β-cell volume is maintained at this stage of disease progression. This evidence concerns the gene INS and Impaired glucose tolerance.